Denmark Press Releases

Published on February 8, 2024 - 12:35 GMT

Annual report 2023: ALK delivers 9% sales growth with profits up 50%

08 February 2024 ALK’s (ALKB:DC / OMX: ALK B / AKBLF) Board of Directors has approved the company’s 2023 annual report. Following a robust performance in Q4, full-year results were in line with the latest outlook. ALK expects to continue its growth …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on February 8, 2024 - 11:20 GMT

Evaxion erfüllt wieder die Anforderungen der Nasdaq an den Mindestangebotspreis

KOPENHAGEN, Dänemark, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) („Evaxion“ oder das „Unternehmen“), ein im klinischen Stadium tätiges Biotechnologieunternehmen, das sich auf die Entwicklung von KI-gestützten Immuntherapien (AI- …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on February 8, 2024 - 11:20 GMT

Evaxion répond de nouveau aux exigences du Nasdaq en matière de prix minimum de l'offre

COPENHAGUE, Danemark, 08 févr. 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ : EVAX), ci-après « Evaxion » ou la « Société », une société de biotechnologie axée sur la recherche clinique spécialisée dans le développement de vaccins à partir de sa …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on February 7, 2024 - 15:57 GMT

ROCKWOOL reports satisfactory 2023 performance in a difficult environment

HEDEHUSENE, Denmark, Feb. 07, 2024 (GLOBE NEWSWIRE) -- ROCKWOOL’s full year 2023 sales reached 3620 MEUR, a decrease of four percent in local currencies and seven percent in reported figures. EBIT in 2023 ended at 518 MEUR, up 29 percent, with an EBIT …

Distribution channels: Building & Construction Industry ...

Published on February 7, 2024 - 13:30 GMT

Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement

COPENHAGEN, Denmark, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that on February 05, 2024, …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on February 7, 2024 - 11:13 GMT

Evaxion gibt den Abschluss seiner Emission in Höhe von 15 Mio. USD bekannt

KOPENHAGEN, Dänemark, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) („Evaxion“ oder das „Unternehmen“), ein TechBio-Unternehmen im klinischen Stadium, das sich auf die Entwicklung von AI-Immunology™-gestützten Impfstoffen …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on February 7, 2024 - 11:13 GMT

Evaxion annonce la clôture de son offre publique à 15 millions de dollars

COPENHAGUE, Danemark, 07 févr. 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ : EVAX) (« Evaxion » ou la « Société »), une société de biotechnologie axée sur la recherche clinique spécialisée dans le développement de vaccins basés sur sa plateforme d …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on February 6, 2024 - 14:00 GMT

MontaVista Announces Built-in Readiness for Enterprise Linux to Address Entire Software Supply Chain Security

MontaVista incorporates Zero Trust and Secure-by-Design features for MVShield and MVSecure to secure the entire Software Supply Chain. SAN JOSE, CALIFORNIA, UNITED STATES, February 6, 2024 /⁨EINPresswire.com⁩/ -- MontaVista® Software, LLC, a leader in …

Distribution channels: Automotive Industry, Aviation & Aerospace Industry ...

Published on February 6, 2024 - 10:59 GMT

ESGRI (ESG Reporting Intelligence) announces Partnership with Ulbaekgaard to support ESG-strive in Europe

ESG Reporting Intelligence is excited to announce a strategic partnership with Ulbaekgaard to foster innovation and expanding market reach into Europe. SYDNEY, NEW SOUTH WALES, AUSTRALIA, February 6, 2024 /⁨EINPresswire.com⁩/ -- ESG Reporting Intelligence …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 6, 2024 - 13:30 GMT

Evaxion Announces Closing of $15 Million Public Offering

COPENHAGEN, Denmark, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the closing on February 5, …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on February 6, 2024 - 08:00 GMT

GN expands its most advanced hearing aid family ReSound Nexia into new range of styles all offering the next era of connectivity

The ReSound Nexia™ portfolio* offers a full range of popular styles, top-rated for sound quality and hearing in noise.1 Designed to take advantage of the new Bluetooth® Low Energy (LE) Audio benefits, ReSound Nexia is the world’s first hearing aid to …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on February 5, 2024 - 08:38 GMT

Valentine's Day and the DYU A1F Electric Bike: Facilitating Shared Journeys

NETHERLANDS, February 5, 2024 /⁨EINPresswire.com⁩/ -- A Journey of Togetherness Begins with a Single Ride This Valentine's Day, DYU invites couples to embark on a journey of love, laughter, and exploration with the A1F 16 Inch Full Folding Electric …

Distribution channels: Automotive Industry, Building & Construction Industry ...

Published on February 5, 2024 - 03:11 GMT

Announcing the A' Home Appliances Design Award Call for Entries 2024

The A' Home Appliances Design Award 2024 welcomes global innovators to showcase creativity and design excellence in the home appliances sector. COMO, CO, ITALY, February 4, 2024 /⁨EINPresswire.com⁩/ -- Introduction The A' Home Appliances Design …

Distribution channels: Business & Economy, Consumer Goods ...

Published on February 5, 2024 - 08:30 GMT

ALK’s 2030 CO2 reduction targets have been approved by SBTi

ALK’s near-term carbon reduction targets for scope 1, 2 and 3 have been validated and approved by the Science Based Targets initiative. Today, ALK announces that its near-term carbon reduction targets have been confirmed by the Science Based Targets …

Distribution channels:

Published on February 2, 2024 - 16:09 GMT

Global Protein Bar Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors

The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033 LONDON, GREATER LONDON, UK, February 2, 2024 /⁨EINPresswire.com⁩/ -- The Business Research Company’s “Protein Bar Global Market …

Distribution channels: Business & Economy, Consumer Goods ...

Published on February 2, 2024 - 10:58 GMT

Readynez Takes Lead in Sustainable IT Training: Unveils 2024 Sustainability Report for a Greener Future in IT Education

Readynez Guides IT Training to a Green Future - Reveals 2024 Sustainability Report, Showcasing 99% Onsite Course Reduction & Substantial CO2 Cut. DENMARK, February 2, 2024 /⁨EINPresswire.com⁩/ -- The IT training industry, long plagued by a substantial …

Distribution channels: Education, IT Industry ...

Published on February 2, 2024 - 09:05 GMT

Cercare Medical Updates Neurosuite for Enhanced Stroke Diagnosis and Management

CMN V14 is here! Revolutionizing stroke care with advanced features, global accessibility, and a focus on precision. A new era in neuroimaging begins. AARHUS C, DANEMARK, February 2, 2024 /⁨EINPresswire.com⁩/ -- AARHUS, DENMARK, 02 February 2024: Cercare …

Distribution channels: Business & Economy, Companies ...

Published on February 2, 2024 - 13:57 GMT

Evaxion Biotech gibt Preisfestsetzung für Emission in Höhe von 15 Mio. USD bekannt

KOPENHAGEN, Dänemark, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) („Evaxion“ oder das „Unternehmen“), ein TechBio-Unternehmen im klinischen Stadium, das sich auf die Entwicklung von KI-Immunologie™-gestützten Impfstoffen …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on February 2, 2024 - 13:57 GMT

Evaxion Biotech fixe le prix de son offre publique à 15 millions de dollars

COPENHAGUE, Danemark, 02 févr. 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ : EVAX), ci-après « Evaxion » ou la « Société », une société de biotechnologie axée sur la recherche clinique spécialisée dans le développement de vaccins basés sur sa …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on February 1, 2024 - 14:20 GMT

Evaxion Biotech Announces Pricing of $15 Million Public Offering

COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the pricing of a public …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Denmark Press Releases Distributed by EIN Presswire